Browsing Tag
FDA
341 posts
Hims & Hers Health soars over 10% after Wegovy rollout, Q1 strength, and analyst upgrades
Hims & Hers Health stock jumped 10.36% on May 16, 2025, after a Wegovy rollout, strong Q1 earnings, and analyst upgrades boosted investor confidence.
May 17, 2025
TransMedics stock jumps nearly 20% after Q1 results, regulatory tailwinds for OCS heart system
Why Did TransMedics Stock Rise Nearly 20%? TransMedics Group, Inc. (NASDAQ: TMDX) witnessed a sharp surge of 19.64%…
May 10, 2025
Prescient Therapeutics secures FDA fast track for PTX-100 to advance CTCL treatment strategy
Find out how Prescient Therapeutics’ PTX-100 just gained FDA Fast Track status, accelerating the path to treating relapsed CTCL.
April 16, 2025
Johnson & Johnson’s next-gen surgical robot OTTAVA enters operating rooms for the first time
Find out how Johnson & Johnson MedTech's OTTAVA robotic surgical system is advancing minimally invasive surgery with its first completed clinical trial cases.
April 15, 2025
Abbott advances coronary artery disease treatment with new intravascular lithotripsy trial
Abbott’s Coronary Intravascular Lithotripsy (IVL) System gets FDA approval for a clinical trial to enhance coronary artery disease treatment—learn more.
March 25, 2025
Danone faces quality concerns as FDA recalls International Delight coffee creamers
Danone North America has issued a voluntary recall of over 75,000 bottles of International Delight coffee creamer following…
March 18, 2025
Laplace Interventional advances life-saving heart valve technology with $22m funding round
Laplace Interventional, a Minnesota-based medical device company pioneering transcatheter tricuspid valve replacement technology, has secured $22 million in…
March 17, 2025
Sanofi advances flu vaccine production with FDA-approved strains for 2025-26 season
Sanofi has confirmed that it is advancing its flu vaccine production for the 2025-26 flu season, aligning with…
March 15, 2025
AbbVie’s ELAHERE demonstrates 32% reduction in death risk for ovarian cancer patients
A final analysis of the Phase 3 MIRASOL trial has confirmed that ELAHERE (mirvetuximab soravtansine-gynx) provides a significant…
March 15, 2025
Dr. Reddy’s Laboratories recalls Levetiracetam Injection in U.S. over mislabeling concerns
Dr. Reddy’s Laboratories Limited has initiated a nationwide recall of a batch of Levetiracetam in 0.75% Sodium Chloride…
March 14, 2025